PATADAY ONCE DAILY RELIEF (nda021545)- (EQ 0.2% BASE)

Generic Name	OLOPATADINE HYDROCHLORIDE	Innovator	ALCON LABS INC
Dosage	EQ 0.2% BASE
ParaIV Filing	Yes	505(b)2 Filing	No
Last Patent Expiry	2024-May-12	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	PAZEO is a mast cell stabilizer indicated for the treatment of ocular itching associated with allergic conjunctivitis.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
7	1	6

Other Developers

Total Other Developers	3

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 0.2% BASE	**	**	Up	2	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	5

Manufacturing Details of PATADAY ONCE DAILY RELIEF